IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
Provided By PR Newswire
Last update: Apr 28, 2025
CAESAREA, Israel, April 28, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced its participation at the Society of Breast Imaging (SBI) 2025 Breast Imaging Symposium which took place April 24-27, 2025 in Colorado Springs, Colorado.
Read more at prnewswire.com
